Stock Analiz

Elanco Animal Health Inc (ELAN) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Elanco Animal Health’s revenue went from $2.9B in fiscal 2016 to $4.7B in fiscal 2025, growth of about 5.5% a year.

Net income in fiscal 2025 was -$232M, a net margin of -4.9%; the best year in this period was 2024 with $338M.

Over the twelve months to September 30, 2026, revenue was $5.1B and net income -$147M.

Free cash flow was $284M in fiscal 2025 and positive in 9 of the 10 years shown.

The diluted share count rose 69% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $2.9B162017: $2.9B172018: $3.1B182019: $3.1B192020: $3.3B202021: $4.8B212022: $4.4B222023: $4.4B232024: $4.4B242025: $4.7B25$4.7B
Net income
2016: -$48M162017: -$311M172018: $86M182019: $68M192020: -$574M202021: -$483M212022: -$78M222023: -$1.2B232024: $338M242025: -$232M25-$232M
Free cash flow
2016: $46M162017: $75M172018: $353M182019: $84M192020: -$176M202021: $324M212022: $281M222023: $131M232024: $394M242025: $284M25$284M
EPS (diluted)
2016: $-0.16162017: $-1.06172018: $0.28182019: $0.18192020: $-1.30202021: $-0.99212022: $-0.16222023: $-2.50232024: $0.68242025: $-0.4725$-0.47

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$5.1B$4.7B$4.4B$4.4B$4.4B$4.8B$3.3B$3.1B$3.1B$2.9B$2.9B
Gross profit$2.9B$2.6B$2.4B$2.5B$2.5B$2.6B$1.6B$1.6B$1.5B$1.4B$1.5B
Operating income-$92M-$224M$488M-$1.2B-$72M-$571M-$675M$78M$114M-$233M-$22M
Net income-$147M-$232M$338M-$1.2B-$78M-$483M-$574M$68M$86M-$311M-$48M
EPS (diluted)$-0.30$-0.47$0.68$-2.50$-0.16$-0.99$-1.30$0.18$0.28$-1.06$-0.16
R&D$381M$368M$344M$327M$321M$369M$329M$270M$247M$252M$266M
Revenue growth—+6.2%+0.5%+0.1%−7.4%+45.6%+6.6%+0.1%+6.2%−0.8%—

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$614M$560M$541M$271M$452M$483M-$41M$224M$487M$174M$156M
Capital spending-$206M-$276M-$147M-$140M-$171M-$159M-$135M-$140M-$134M-$99M-$110M
Free cash flow$408M$284M$394M$131M$281M$324M-$176M$84M$353M$75M$46M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks———————————
Stock-based pay$77M$68M$55M$46M$59M$66M$47M$49M$26M$25M$20M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$545M$468M$352M$345M$638M$495M$334M$475M$323M$259M
Debt—$4.1B$4.4B$5.9B$6.0B$6.5B$6.3B$2.4B$2.5B$0—
Equity—$6.5B$6.1B$6.2B$7.3B$7.5B$8.5B$5.5B$5.2B$7.8B$7.0B
Total assets—$13.4B$12.6B$14.4B$15.5B$16.5B$17.7B$9.0B$9.0B$8.9B—
Shares (diluted)506M496M497M492M488M487M441M370M314M293M293M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin56.2%55.0%54.9%56.3%56.6%55.2%49.1%52.1%48.7%48.3%51.6%
Operating margin-1.8%-4.8%11.0%-27.1%-1.6%-12.0%-20.6%2.5%3.7%-8.1%-0.8%
Net margin-2.9%-4.9%7.6%-27.9%-1.8%-10.1%-17.5%2.2%2.8%-10.8%-1.6%
FCF margin7.9%6.0%8.9%3.0%6.4%6.8%-5.4%2.7%11.5%2.6%1.6%
ROIC—-1.7%3.2%-7.8%-0.4%-3.5%-3.9%0.9%1.1%-2.4%-0.2%
ROE—-3.5%5.5%-19.8%-1.1%-6.4%-6.8%1.2%1.7%-4.0%-0.7%

Frequently asked questions

What is Elanco Animal Health’s annual revenue?

$4.7B in fiscal 2025 and $5.1B over the twelve months to September 30, 2026.

How much profit does Elanco Animal Health make?

Net income was -$232M in fiscal 2025 (net margin -4.9%).

Is Elanco Animal Health’s revenue growing?

Yes: revenue rose 6.2% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.